Si-Bone Inc (SIBN) Stock Analysis

Si-Bone Inc (SIBN) is a publicly traded company in the HEALTHCARE sector. It trades at $13.87, carries a market capitalization of $615.13M. This page summarizes the public market data, fundamentals, and frequently asked questions for SIBN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $13.87
• Market Cap: $615.13M
• EPS: $-0.39
• 52-Week High: $21.89
• 52-Week Low: $11.48

Market Sentiment

Si-Bone Inc currently has a Neutral sentiment score of -0.03.

About Si-Bone Inc

Si-Bone, Inc. is a leading medical device company specializing in the development of innovative implantable solutions for the surgical treatment of sacropelvic disorders. Headquartered in Santa Clara, California, the firm operates both in the United States and internationally, aiming to enhance patient outcomes through its advanced technology portfolio. With a focus on addressing unmet clinical needs in spine surgery, Si-Bone is well-positioned to leverage the growing demand for minimally inv...

GNG Research Analysis

GNG Research scores Si-Bone Inc (SIBN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SIBN.

Frequently Asked Questions

Does SIBN pay dividends?

Si-Bone Inc (SIBN) does not currently pay a regular dividend.

What is SIBN's market cap?

Si-Bone Inc (SIBN) has a market capitalization of $615.13M with a current stock price of $13.87.